Tenet Healthcare Corporation (NYSE:THC) Receives $244.16 Consensus Target Price from Analysts

Tenet Healthcare Corporation (NYSE:THC) has been assigned an average rating of “Moderate Buy” from the twenty-two research firms that are presently covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation and nineteen have given a buy recommendation to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $244.1579.

Several research firms recently weighed in on THC. Guggenheim cut their price target on shares of Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Stephens dropped their target price on shares of Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating on the stock in a research report on Monday, May 4th. Jefferies Financial Group upped their target price on Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a report on Thursday, February 12th. KeyCorp dropped their price target on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Finally, Leerink Partners upped their price objective on Tenet Healthcare from $255.00 to $264.00 and gave the company an “outperform” rating in a research note on Friday, February 20th.

Tenet Healthcare Stock Up 0.1%

THC stock opened at $196.13 on Friday. The stock’s 50 day moving average is $201.27 and its 200-day moving average is $203.88. Tenet Healthcare has a twelve month low of $146.60 and a twelve month high of $247.21. The firm has a market capitalization of $16.89 billion, a PE ratio of 10.20, a P/E/G ratio of 1.30 and a beta of 1.30. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The business had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.39 billion. During the same period in the prior year, the firm posted $4.36 EPS. Tenet Healthcare’s quarterly revenue was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Sell-side analysts expect that Tenet Healthcare will post 17.56 EPS for the current fiscal year.

Insider Buying and Selling

In other Tenet Healthcare news, EVP Paola M. Arbour sold 6,500 shares of Tenet Healthcare stock in a transaction dated Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total value of $1,549,795.00. Following the sale, the executive vice president owned 29,291 shares of the company’s stock, valued at approximately $6,983,853.13. The trade was a 18.16% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider R. Scott Ramsey sold 8,017 shares of the stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $232.70, for a total transaction of $1,865,555.90. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 46,517 shares of company stock worth $10,943,111. Insiders own 0.81% of the company’s stock.

Hedge Funds Weigh In On Tenet Healthcare

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD lifted its stake in shares of Tenet Healthcare by 1.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 7,490,350 shares of the company’s stock valued at $1,488,484,000 after buying an additional 119,809 shares in the last quarter. Boston Partners raised its holdings in Tenet Healthcare by 15.7% during the 4th quarter. Boston Partners now owns 3,642,136 shares of the company’s stock valued at $723,804,000 after acquiring an additional 494,581 shares during the period. AQR Capital Management LLC lifted its position in shares of Tenet Healthcare by 20.3% during the fourth quarter. AQR Capital Management LLC now owns 2,256,539 shares of the company’s stock worth $448,419,000 after acquiring an additional 380,116 shares in the last quarter. Ameriprise Financial Inc. grew its position in shares of Tenet Healthcare by 8.0% in the second quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock valued at $373,020,000 after purchasing an additional 157,109 shares in the last quarter. Finally, Norges Bank bought a new stake in shares of Tenet Healthcare during the 4th quarter valued at $248,494,000. Institutional investors own 95.44% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.